305.23 USD
↘ 0.45 (0.15%)AT CLOSE (03:59 PM EST)
Shares of Krystal Biotech, Inc. Common Stock (KRYS) are trading at $305.23. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9 and a bullish Golden Cross on the moving averages. Furthermore, KRYS is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Nov 13, 2026.